Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inogen, Inc - Common Stock (NQ:INGN)

8.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inogen, Inc - Common Stock

< Previous 1 2 3 4 5 Next >
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer
From Inogen, Inc.
Via Business Wire
Inogen Announces Second Quarter 2025 Financial Results
From Inogen, Inc.
Via Business Wire
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025
From Inogen, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025. 
Via Benzinga
This United Rentals Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
 
Via Benzinga
Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy
From Inogen, Inc.
Via Business Wire
Inogen Announces First Quarter 2025 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025
From Inogen, Inc.
Via Business Wire
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
From Inogen, Inc.
Via Business Wire
What's Going On With MedTech Focused Inogen Stock On Wednesday?
Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and restructuring risks. 
Via Benzinga
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West
From Inogen, Inc.
Via Business Wire
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
From Inogen, Inc.
Via Business Wire
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
From Inogen, Inc.
Via Business Wire
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
From Inogen, Inc.
Via Business Wire
Inogen Announces Third Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Present at Upcoming Investor Conferences
From Inogen, Inc.
Via Business Wire
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024
From Inogen, Inc.
Via Business Wire
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC
From Inogen, Inc.
Via Business Wire
Inogen Appoints Eric Pauls as Vice President of Sales, North America
From Inogen, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
Inogen Announces Second Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
3 Stocks Under $10 With the Potential for Massive Gains
Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries. 
Via InvestorPlace
Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024
From Inogen, Inc.
Via Business Wire
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
From Inogen, Inc.
Via Business Wire
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
From Inogen, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.